Inclusion Criteria:

- 18 years of age or older

- Woman presenting with: enlarging fibroadenoma (less than 2 cm in diameter or woman
over 40 years old with fibroadenoma less than 2 cm in diameter) or suspect malignant
nodule (less than 2 cm in diameter) or a cluster of microcalcification or a malignant
nodule (size greater than 3 cm) diagnosed with mammography and/or MRI and/or United
States (US) examination performed within 1 month before the study.

- Woman scheduled for biopsy or surgery within 1 month from the examination.

Exclusion Criteria:

- Patients who have already performed a biopsy on the lesion during investigation

- Any contraindication to perform a contrast-enhanced MRI examination for the patients
presenting with a malignant nodule (size greater than 3 cm)

- Patients previously entered in this study or having received an investigational drug
within 30 days prior to admission to this study

- Patients with any medical condition or other circumstances which would significantly
decrease the chances of obtaining reliable data or of achieving the study objectives
(drug dependence, psychiatric disorders, dementia or other reasons)

- Pregnant or nursing female

- Patient known to have a coronary syndrome

- Unstable angina and myocardial infarction

- Acute cardiac failure, Class III/IV cardiac failure

- Severe rhythm disorders

- Acute endocarditis

- Prosthetic valves